- Home
- BRX vs ROIV Comparison
BRX vs ROIV Comparison
Compare BRX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRX
- ROIV
- Stock Information
- Founded
- BRX 2011
- ROIV 2014
- Country
- BRX United States
- ROIV United Kingdom
- Employees
- BRX N/A
- ROIV N/A
- Industry
- BRX Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- BRX Real Estate
- ROIV Health Care
- Exchange
- BRX Nasdaq
- ROIV Nasdaq
- Market Cap
- BRX 8.2B
- ROIV 8.4B
- IPO Year
- BRX 2013
- ROIV N/A
- Fundamental
- Price
- BRX $27.25
- ROIV $10.68
- Analyst Decision
- BRX Buy
- ROIV Strong Buy
- Analyst Count
- BRX 14
- ROIV 8
- Target Price
- BRX $30.38
- ROIV $17.93
- AVG Volume (30 Days)
- BRX 2.7M
- ROIV 4.0M
- Earning Date
- BRX 02-10-2025
- ROIV 02-10-2025
- Dividend Yield
- BRX 4.22%
- ROIV N/A
- EPS Growth
- BRX 9.90
- ROIV N/A
- EPS
- BRX 1.11
- ROIV N/A
- Revenue
- BRX $1,285,054,000.00
- ROIV $122,585,000.00
- Revenue This Year
- BRX N/A
- ROIV $15.98
- Revenue Next Year
- BRX $4.57
- ROIV N/A
- P/E Ratio
- BRX $24.56
- ROIV N/A
- Revenue Growth
- BRX 3.21
- ROIV 140.04
- 52 Week Low
- BRX $20.80
- ROIV $9.76
- 52 Week High
- BRX $30.67
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- BRX 52.93
- ROIV 42.58
- Support Level
- BRX $27.14
- ROIV $10.33
- Resistance Level
- BRX $27.62
- ROIV $10.86
- Average True Range (ATR)
- BRX 0.62
- ROIV 0.27
- MACD
- BRX 0.14
- ROIV 0.02
- Stochastic Oscillator
- BRX 59.20
- ROIV 29.96
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.